Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Thyroid Gland Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
5 drugs · 9 active trials
5 drugs · 3 active trials
10 drugs · 42 active trials
Outside the funnel: Phase not stated 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 11 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Vemurafenib | Phase 3 | Phase 3 | 4 | 2 | 1 | 7 | 0 | — | — | Nov 7, 2012 |
| Cobimetinib | Phase 3 | Phase 3 | 3 | 2 | 1 | 3 | 0 | — | — | Jul 27, 2017 |
| Paclitaxel | Phase 3 | Phase 3 | 2 | 0 | 1 | 6 | 0 | — | — | 2007-08 |
| Metformin | Phase 3 | Phase 3 | 0 | 0 | 1 | 2 | 0 | — | — | 2010-04 |
| Carboplatin | Phase 3 | Phase 3 | 0 | 0 | 1 | 1 | 0 | — | — | 2007-08 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.